Well done to our team of 5 million on eliminating COVID-19 in New Zealand. Find out what PHARMAC is doing to support the recovery.
Medicine and medical device supply
PHARMAC and suppliers are all working to minimise any impacts of the general supply chain and manufacturing disruptions caused by COVID-19.
It's likely there will be global impacts on medicine manufacture and supply chains for the remainder of 2020 and potentially beyond.
Other than some funded vaccines, PHARMAC itself does not purchase or hold stocks of any medicine.
Who to contact
If you're a pharmacist with queries about stock, we recommend you contact your wholesaler or the supplier.
If you have any queries about PHARMAC's response, contact:
Last updated: 7 July 2020
COVID-19 information for:
OIA responses regarding COVID-19
We are part of the All-of-Government COVID-19 vaccine strategy.